Inhibition of cell migration and invasion mediated by the TAT-RasGAP317-326 peptide requires the DLC1 tumor

D Barras1, G Lorusso2, C Rüegg2

  • 1Department of Physiology, University of Lausanne, Lausanne, Switzerland.

Oncogene
|November 12, 2013
PubMed

Insights

The peptide TAT-RasGAP(317-326) enhances tumor cell death and also inhibits cancer cell migration and invasion. This peptide alters the actin cytoskeleton and focal adhesions, offering a dual-action therapeutic strategy.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • The peptide TAT-RasGAP(317-326) is derived from p120 RasGAP and a cell-penetrating TAT peptide.
  • It is known to sensitize tumor cells to anticancer treatments, promoting cell death.

Purpose of the Study:

  • To investigate the effects of TAT-RasGAP(317-326) on cancer cell adhesion, migration, and invasion.
  • To elucidate the molecular mechanisms underlying these effects, particularly the role of cytoskeletal and adhesion proteins.

Main Methods:

  • Treatment of various tumor cells with TAT-RasGAP(317-326).
  • Assessment of cell adherence, migration, and invasion assays.
  • Analysis of actin cytoskeleton and focal adhesion dynamics.
  • Investigation of the involvement of integrins, Rho GTP-binding proteins, and deleted in liver cancer-1 (DLC1).

Main Results:

  • TAT-RasGAP(317-326) significantly increased cell adherence.
  • The peptide inhibited cell migration and matrix invasion.
  • These effects were associated with modifications in the actin cytoskeleton and focal adhesion distribution.
  • Pro-adhesive effects were independent of integrins and Rho GTP-binding proteins.
  • The tumor suppressor DLC1 was found to be essential for the pro-adhesive and anti-migratory actions of TAT-RasGAP(317-326).

Conclusions:

  • TAT-RasGAP(317-326) possesses dual functions: promoting tumor cell death and inhibiting cancer cell migration and invasion.
  • The peptide's anti-migratory and pro-adhesive effects are mediated through DLC1, independent of classical integrin and Rho GTPase pathways.
  • These findings highlight TAT-RasGAP(317-326) as a promising agent for cancer therapy with multifaceted mechanisms of action.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K